Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Keratinocyte Carcinoma; Basal Cell Carcinomas; Squamous Cell Carcinoma; Skin Cancer Interventions: Drug: Tirbanibulin ointment 1%; Device: non-ablative fractional laser Sponsors: Bruce Robinson, MD Recruiting Conditions: Keratinocyte Carcinoma; Basal...

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo Sponsors: Aclaris Therapeutics, Inc. Recruiting Conditions: Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema Interventions: Drug: ATI-045; Drug: Placebo...

Muscle Injury RTP Design in Football; Effects of Backward Design vs Forward Design: A Randomized Controlled Trial

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Muscle Injuries; Football Players Interventions: Other: Return to play program with progressive design; Other: Return to play program with regressive design Sponsors: Universitat de les Illes Balears Not yet recruiting Conditions: Muscle Injuries;...

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Staphylococcus Haemolyticus; Staphylococcal Infections; Sepsis; Catheter-Related Infections; Infant, Newborn; Intensive Care Units, Neonatal; Cross Infection; Drug Resistance, Bacterial Sponsors: Centre Hospitalier de Saint-Denis Completed Conditions:...

Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

by palligoelme@gmail.com | Jun 10, 2025 | Clinical Trials

​ Conditions: Renal Impairment Interventions: Drug: BPN14770 Sponsors: Shionogi Not yet recruiting Conditions: Renal Impairment Interventions: Drug: BPN14770 Sponsors: Shionogi Not yet recruiting